Organon & Co. ( OGN) - Key Metrics
OGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $5.79 | -$0.79 | ? | ? |
| 2025Q3 | $6.16 | $0.62 | $1.02 | $0.57 |
| 2025Q2 | $6.13 | $0.56 | $0.85 | $0.70 |
| 2025Q1 | $5.87 | $0.34 | $0.29 | -$0.09 |
OGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | -2.54% | -2.27 |
| 2025Q3 | 1.87% | 4.34 |
| 2025Q2 | 6.90% | 4.34 |
| 2025Q1 | 81.61% | 11.03 |
OGN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 12.05% | ? |
| 2025Q4 | 5.15% | 0.28% |
| 2025Q3 | 5.37% | 0.11% |
| 2025Q2 | 7.19% | 0.40% |
| 2025Q1 | -0.57% | 1.85% |
OGN
Price: $13.40
Dividend Yield: 0.60%
Forward Dividend Yield: 0.60%
Payout Ratio: 28.87%
Dividend Per Share: 0.08 USD
Earnings Per Share: 0.93 USD
P/E Ratio: 14.31
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 1.6 million
Market Capitalization: 3.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 6
DGR3: -7.74%